TY - JOUR
T1 - Management of endometrial cancer in Asia
T2 - consensus statement from the Asian Oncology Summit 2009
AU - Tangjitgamol, Siriwan
AU - Anderson, Benjamin O.
AU - See, Hui Ti
AU - Lertbutsayanukul, Chawalit
AU - Sirisabya, Nakarin
AU - Manchana, Tarinee
AU - Ilancheran, Arunachalam
AU - Lee, Khai Mun
AU - Lim, Siew Eng
AU - Chia, Yin Nin
AU - Domingo, Efren
AU - Kim, Young Tak
AU - Lai, Chyong Huey
AU - Dali, Ahmad Zailani Hatta Mohd
AU - Supakapongkul, Wisit
AU - Wilailak, Sarikapan
AU - Tay, Eng Hseon
AU - Kavanagh, John
PY - 2009/11
Y1 - 2009/11
N2 - Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.
AB - Endometrial cancer is one of the gynaecological cancers that carries good overall prognosis because it is often detected at early stages of disease. The International Federation of Gynecology and Obstetrics replaced clinical staging with surgical staging in 1988 and updated the system in 2009. Controversies remain regarding the recommended screening protocol for women with a high risk of endometrial cancer, the role and benefit of retroperitoneal lymph-node dissection, the necessity of ovarian resection, the benefit and type of adjuvant radiation therapy, and the safety of hormone-replacement therapy after treatment. This article reviews the available evidence for optimum management of endometrial cancer and how management strategies can be applied in Asian countries with different levels of health-care resource availability and economic development. An overview of the literature for endometrial-cancer screening, diagnosis, and management is discussed. Consensus statements are formulated on the basis of basic, limited, enhanced, and maximum health-care resource availability, using the framework provided by the Breast Health Global Initiative.
KW - ADJUVANT TREATMENT
KW - FOLLOW-UP
KW - INTERMEDIATE-RISK
KW - MRC ASTEC
KW - PELVIC RADIATION-THERAPY
KW - PHASE-III TRIAL
KW - POSTOPERATIVE RADIOTHERAPY
KW - RANDOMIZED-TRIAL
KW - REPLACEMENT THERAPY
KW - STAGE-I
UR - http://www.scopus.com/inward/record.url?scp=71249155601&partnerID=8YFLogxK
U2 - 10.1016/S1470-2045(09)70290-6
DO - 10.1016/S1470-2045(09)70290-6
M3 - 文献综述
C2 - 19880066
AN - SCOPUS:71249155601
SN - 1470-2045
VL - 10
SP - 1119
EP - 1127
JO - The Lancet Oncology
JF - The Lancet Oncology
IS - 11
ER -
